<?xml version="1.0" encoding="UTF-8"?>
<p>Participant flow through the study is shown in Figure 
 <xref rid="cam41690-fig-0001" ref-type="fig">1</xref>. Data were analyzed from 44 MM patients undergoing ASCT at Mount Sinai Hospital in New York, NY. Eligibility criteria included: first ASCT; 21 years of age or older; and English language proficiency. Exclusion criteria included: previous stem cell transplantation (autologous or allogeneic), pregnancy, eye diseases limiting the patient's ability to process light (eg, untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems, or retina damage), secondary cancer diagnosis within the last 5 years, severe sleep disorders (eg, Narcolepsy), history of bipolar disorder or manic episodes (a contra‐indication for light treatment), severe psychological impairment (eg, hospitalization for depressive episode in the past 12 months), and/or previous use of light therapy to alleviate fatigue or depressive symptoms. The Mt. Sinai Program for the Protection of Human Subjects approved the study.
</p>
